TLDR:
- Discussion on challenges in addiction treatment access
- Race for oral treatments for obesity and venture capital trends in biotech
In the latest episode of “The Readout LOUD,” STAT’s biotech podcast, topics discussed include the barriers to accessing addiction treatments, the competition in developing oral treatments for obesity, and the dynamics of venture capital in the biotech industry. Lev Facher from STAT provides insights into why American society is hindering the use of life-saving tools during the opioid overdose epidemic.
The episode also covers the current trends in biotech financing and the efforts to create effective oral therapies for obesity, including Novo Nordisk’s developments in this area. The podcast highlights the challenges faced by small companies in the obesity drug competition and the shifting landscape of venture capital investments in the life sciences sector.
Listeners can find more information on addiction medicine, biotech financing, Novo Nordisk’s oral obesity treatment, and other related topics mentioned in the episode. The podcast is available on popular platforms like Apple Podcasts, Spotify, and Stitcher.
Overall, “The Readout LOUD” delves into various issues impacting the biotech industry, offering valuable insights and updates on the latest developments in healthcare and medicine.
